Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Selinexor in Extramedullary Disease in Multiple Myeloma: NCT07200102 Clinical Landscape Report 2026
15 October 2026
NCT07200102 clinical landscape for Extramedullary Disease in Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
BCMA-GPRC5D CAR-T Cells(Guangzhou Bio-gene Technology) in Multiple Myeloma: NCT07196124 Clinical Landscape Report 2026
15 October 2026
NCT07196124 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YL-202 in Locally Advanced Malignant Solid Neoplasm: NCT07202364 Clinical Landscape Report 2026
15 October 2026
NCT07202364 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
A-CAR028 in Relapsing acute myeloid leukemia: NCT07198867 Clinical Landscape Report 2026
15 October 2026
NCT07198867 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Gemcitabine Hydrochloride in Non-Muscle Invasive Bladder Neoplasms: NCT07198451 Clinical Landscape Report 2026
15 October 2026
NCT07198451 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Efineptakin alfa (Genexine) in Relapse multiple myeloma: NCT07200089 Clinical Landscape Report 2026
15 October 2026
NCT07200089 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulfamethoxazole/Trimethoprim in Bacterial Infections: NCT07202091 Clinical Landscape Report 2026
15 October 2026
NCT07202091 clinical landscape for Bacterial Infections: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulfamethoxazole/Trimethoprim in Multiple Myeloma: NCT07202078 Clinical Landscape Report 2026
15 October 2026
NCT07202078 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulfamethoxazole/Trimethoprim in Common Variable Immunodeficiency: NCT07202052 Clinical Landscape Report 2026
15 October 2026
NCT07202052 clinical landscape for Common Variable Immunodeficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells) in Bone marrow depression: NCT07201233 Clinical Landscape Report 2026
15 October 2026
NCT07201233 clinical landscape for Bone marrow depression: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Toripalimab in Muscle Invasive Bladder Carcinoma: NCT07201675 Clinical Landscape Report 2026
15 October 2026
NCT07201675 clinical landscape for Muscle Invasive Bladder Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Penfluridol in Small Cell Carcinoma: NCT07206563 Clinical Landscape Report 2026
15 October 2026
NCT07206563 clinical landscape for Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.